APA (7th ed.) Citation

Yokomaku, Y., Teruya, K., Watanabe, D., Endo, T., Minami, R., Taguchi, N., . . . Oka, S. Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in treatment-naïve and treatment-experienced people with HIV: 12-month virologic effectiveness and safety outcomes in the BICSTaR Japan cohort. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Yokomaku, Yoshiyuki, et al. Bictegravir/emtricitabine/tenofovir Alafenamide (B/F/TAF) in Treatment-naïve and Treatment-experienced People with HIV: 12-month Virologic Effectiveness and Safety Outcomes in the BICSTaR Japan Cohort. Public Library of Science (PLoS).

MLA (9th ed.) Citation

Yokomaku, Yoshiyuki, et al. Bictegravir/emtricitabine/tenofovir Alafenamide (B/F/TAF) in Treatment-naïve and Treatment-experienced People with HIV: 12-month Virologic Effectiveness and Safety Outcomes in the BICSTaR Japan Cohort. Public Library of Science (PLoS).